MARISSA PETTIT: Open Payments
NPI 1831528090 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,452 in 34 payments from 8 companies in 2025. Trend: 2023 $367 · 2024 $1,432 · 2025 $1,452
Long term medical supply or device loan: $1,000Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $1,057 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Daiichi Sankyo Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $54 |
| Gilead Sciences, Inc. | 2 | $48 |
| pharmaand GmbH | 1 | $26 |
| BeOne Medicines USA, Inc. | 1 | $22 |
Products named: KISQALI, ENHERTU, VERZENIO, Trodelvy, LYNPARZA, Rubraca, KEYTRUDA, BRUKINSA.
Industry payments across NM — which companies pay providers there.
